Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001910662-25-000003

SVP, CHIEF FINANCIAL OFFICER sold 2,227 shares at an average $77.95 ($173,584)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

LaBrosse Nicole · SVP, CHIEF FINANCIAL OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-22 Sale : show line 1 in the form 10b5-1 −1,913 $77.83 $148,883 22,393 D
2025-09-22 Sale : show line 2 in the form 10b5-1 −314 $78.67 $24,701 22,079 D
Open-market sales · 2,227 sh · avg $77.95 · $173,584
Loading xslF345X05/form4-09232025_080958.xml…